Cipla unit recalls one lot of medication in US due to seal integrity issue

Drug major Cipla's subsidiary is voluntarily recalling one lot of medication in the US due to seal integrity issues. InvaGen Pharmaceuticals Inc, USA, is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP (500 mg), at the consumer level due to seal integrity issues, allowing for powder leakage from the pouch, the Mumbai-based drug maker said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1JjCqbl
via IFTTT